Docoh
Loading...
Sign up Log in

FNAM Evolutionary Genomics

Company profile

Ticker
FNAM
Exchange
OTC
Employees
Incorporated
Nevada
Location
Colorado
Fiscal year end
Dec 31
Sector
Health Technology > Agriculture
Industry (SIC)
Services - Commercial Physical & Biological Research
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • National Research ...
Former names
Fona, Inc.
SEC CIK
0000884363
Corporate docs
IRS number
264369698

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

13 May 21
31 Jul 21
31 Dec 21

Financial summary

Financial statements Chart FNAM financial data
Quarter (USD)
 Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 97.56K 97.56K 97.56K 97.56K 97.56K 97.56K
Cash burn (monthly) 39.43K (positive/no burn) 171.28K 263.65K 64.89K 204.77K
Cash used (since last report) 158.38K n/a 688.05K 1.06M 260.67K 822.56K
Cash remaining -60.82K n/a -590.5K -961.55K -163.11K -725K
Runway (months of cash) -1.5 n/a -3.4 -3.6 -2.5 -3.5

Beta Read what these cash burn values mean

Recent insider trades

FNAM insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
19 May 21 Steve B Warnecke Common Stock Gift Dispose G No No 0 37,500 0 1,827,088
19 May 21 Steve B Warnecke Common Stock Gift Dispose G No No 0 37,500 0 1,864,588
30 Dec 20 Steve B Warnecke Common Stock Gift Dispose G No No 0 15,000 0 1,902,088
30 Dec 20 Steve B Warnecke Common Stock Gift Dispose G No No 0 15,000 0 1,917,088
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: Additionally, Aid, aspect, assessment, awaiting, Committee, cooperation, COSO, criteria, cycle, discarded, discovered, employ, face, fewer, grew, larger, maintaining, plantlet, PPP, President, proven, Relief, seedling, simultaneously, summer, Treadway, unchanged
Removed: Accelerator, advanced, approval, area, assure, awarded, Bill, carried, closest, closing, commercialize, communicated, competition, comprehensive, concept, conducted, consideration, costly, cotton, covered, critically, customer, design, detected, DISCUSSION, end, error, evolution, fiber, genome, hold, human, illustration, imperiled, indefinite, independent, indeterminable, intent, investing, joint, judgment, length, lived, long, maize, marketable, matter, Melinda, monitor, occur, occurring, operated, ownership, phenotyping, political, positively, processed, product, professional, prospect, publicly, pursue, reach, realize, recognizing, remain, represent, retaining, SCN, scope, selected, specific, Sponsored, summarized, supervision, susceptible, timely, tolerate, tomato, trading, trial, WCIC, yielded
From filing 10-Q 2021 Q1

Financial reports

View all
10-Q
2021 Q1
Quarterly report
13 May 21
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
13 Nov 20
10-Q
2020 Q2
Quarterly report
19 Aug 20
NT 10-Q
Notice of late quarterly filing
14 Aug 20
10-Q
2020 Q1
Quarterly report
12 May 20
10-K/A
2019 FY
Annual report (amended)
24 Apr 20
10-K
2019 FY
Annual report
30 Mar 20
10-Q
2019 Q3
Quarterly report
17 Oct 19
10-Q
2019 Q2
Quarterly report
12 Aug 19

Current reports

8-K
Changes in Registrant's Certifying Accountant
4 Oct 18
8-K
Other Events
21 May 18
8-K
Other Events
8 Sep 16
8-K
Unregistered Sales of Equity Securities
24 Feb 16
8-K
Completion of Acquisition or Disposition of Assets
22 Oct 15
8-K
Departure of Directors or Certain Officers
29 Sep 15
8-K/A
Entry into a Material Definitive Agreement
7 Oct 14
8-K
Entry into a Material Definitive Agreement
6 Oct 14
8-K
Entry into a Material Definitive Agreement
11 Jun 14

Registration and prospectus

D
$1.05M in equity, sold $490K, 4 investors
15 May 19
D
$3.15M in equity, sold $2.88M, 25 investors
10 Mar 16
424B3
Prospectus supplement
10 Sep 15
S-4/A
Registration of securities issued in business combination transactions (amended)
27 Aug 15
S-4/A
Registration of securities issued in business combination transactions (amended)
29 Jul 15
S-4/A
Registration of securities issued in business combination transactions (amended)
1 Jul 15
S-4
Registration of securities issued in business combination transactions
1 Apr 15
10-12G
Registration of securities
22 Sep 10

Proxies

No filings

Other

View all
EFFECT
Notice of effectiveness
10 Sep 15
CORRESP
Correspondence with SEC
8 Sep 15
UPLOAD
Letter from SEC
20 Jul 15
CORRESP
Correspondence with SEC
5 Jul 15
UPLOAD
Letter from SEC
30 Apr 15
UPLOAD
Letter from SEC
1 Aug 13
CORRESP
Correspondence with SEC
18 Feb 13
UPLOAD
Letter from SEC
12 Nov 12
CORRESP
Correspondence with SEC
4 Nov 12
UPLOAD
Letter from SEC
13 Sep 12

Ownership

View all
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
21 May 21
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
4 Jan 21
4
EVOLUTIONARY GENOMICS / Mark Virgil Boggess ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / Virginia P. Orndorff ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
8 Sep 16
3
Fona / Mark Virgil Boggess ownership change
20 Oct 15
3
Fona / Virginia P. Orndorff ownership change
20 Oct 15
SC 13D/A
Fona, Inc.
7 Oct 14
SC 13D
Fona, Inc.
15 Jun 14